Sino Biopharmaceutical Ltd (SBMFF)
0.43
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Sino Biopharmaceutical Shareholders Equity (Quarterly): 4.519B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 4.519B |
June 30, 2024 | 4.519B |
December 31, 2023 | 4.299B |
June 30, 2023 | 4.134B |
June 30, 2023 | 4.134B |
December 31, 2022 | 4.312B |
June 30, 2022 | 4.508B |
June 30, 2022 | 4.508B |
June 30, 2021 | 3.801B |
June 30, 2021 | 3.801B |
March 31, 2021 | 2.836B |
December 31, 2020 | 2.563B |
September 30, 2020 | 4.640B |
June 30, 2020 | 4.444B |
June 30, 2020 | 4.444B |
March 31, 2020 | 4.459B |
December 31, 2019 | 2.137B |
September 30, 2019 | 4.292B |
June 30, 2019 | 4.345B |
March 31, 2019 | 4.420B |
December 31, 2018 | 1.893B |
September 30, 2018 | 3.013B |
June 30, 2018 | 3.062B |
March 31, 2018 | 3.192B |
December 31, 2017 | 1.411B |
Date | Value |
---|---|
September 30, 2017 | 1.373B |
June 30, 2017 | 1.274B |
March 31, 2017 | 1.224B |
December 31, 2016 | 1.138B |
September 30, 2016 | 1.129B |
June 30, 2016 | 1.079B |
March 31, 2016 | 1.060B |
December 31, 2015 | 999.80M |
September 30, 2015 | 981.23M |
June 30, 2015 | 944.73M |
March 31, 2015 | 895.52M |
December 31, 2014 | 852.18M |
September 30, 2014 | 806.68M |
June 30, 2014 | 746.47M |
March 31, 2014 | 724.64M |
December 31, 2013 | 707.50M |
September 30, 2013 | 676.61M |
June 30, 2013 | 637.29M |
March 31, 2013 | 620.23M |
December 31, 2012 | 591.08M |
September 30, 2012 | 548.05M |
June 30, 2012 | 515.64M |
December 31, 2011 | 490.52M |
September 30, 2011 | 458.42M |
June 30, 2011 | 463.06M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.137B
Minimum
Dec 2019
4.640B
Maximum
Sep 2020
4.003B
Average
4.312B
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
HUTCHMED (China) Ltd | 740.08M |
Pharmaron Beijing Co Ltd | 1.595B |
Regencell Bioscience Holdings Ltd | 8.219M |
Prenetics Global Ltd | 188.24M |
Uni-Bio Science Group Ltd | 40.04M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.177B |
Total Liabilities (Quarterly) | 3.382B |
Debt to Equity Ratio | 0.2896 |
Current Ratio | 1.149 |
Net Debt Paydown Yield | 3.90% |